Graf Akcie JAZZ (Jazz Pharmaceuticals plc). Diskuze k akciím JAZZ. Aktuální informace JAZZ.

Základní informace o společnosti Jazz Pharmaceuticals plc (Akcie JAZZ)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 7.66B
Hodnota podniku (EV) 13.77B
Tržby 2.626B
EBITDA 854.864M
Zisk 40.164M
Růst v tržbách Q/Q 33.67 %
Růst v tržbách Y/Y 18.46 %
P/E (Cena vůči ziskům) 126.76
Forward P/E 0.11
EV/Sales 5.24
EV/EBITDA 16.11
EV/EBIT 29.38
PEG 4.98
Price/Sales 2.92
P/FCF 10.24
Price/Book 2.09
Účetní hodnota na akcii 67.23
Hotovost na akcii 39.18
FCF vůči ceně 10.03 %
Počet zaměstnanců 1,940
Tržba na zaměstnance 1354000
Profit margin 10.10 %
Operating margin 17.60 %
Gross margin 93.70 %
EBIT margin 17.85 %
EBITDA margin 32.56 %
EPS - Zisk na akcii 1.11
EPS - Kvartální růst 5.12 %
EPS - Očekávaný růst příští rok -24.36 %
Return on assets 0.49 %
Return on equity 1.07 %
ROIC 6.16 %
ROCE 3.80 %
Dluhy/Equity 0.79
Čistý dluh/EBITDA 7.28
Current ratio 3.35
Quick Ratio 1.93
Volatilita 2.77
Beta 0.86
RSI 60.02
Cílová cena analytiků 182
Známka akcie (dle analytiků) 1.39
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 61.364M
Procento shortovaných akcií 10.72 %
Short ratio 9.32 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2007
Země Ireland

Finanční výsledky akcie JAZZ

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$2,363.567$2,161.761$1,890.922$1,618.693$1,487.973$1,324.803
Cost Of Goods Sold$148.917$127.93$121.544$110.188$105.386$102.526
Gross Profit$2,214.65$2,033.831$1,769.378$1,508.505$1,382.587$1,222.277
Research And Development Expenses$335.375$299.726$226.616$198.442$162.297$135.253
SG&A Expenses$854.233$736.942$683.53$544.156$502.892$449.119
Other Operating Income Or Expenses$-136.139-$-42.896--$-31.523
Operating Expenses$1,985.494$1,629.387$1,276.084$1,089.851$896.319$816.583
Operating Income$378.073$532.374$614.838$528.842$591.654$508.22
Total Non-Operating Income/Expense$-102.978$-78.072$-85.375$-87.725$-59.208$-72.287
Pre-Tax Income$275.095$454.302$529.463$441.117$532.446$435.933
Income Taxes$33.517$-73.154$80.162$-47.74$135.236$106.399
Income After Taxes$241.578$527.456$449.301$488.857$397.21$329.534
Other Income------
Income From Continuous Operations$238.616$523.367$447.098$487.848$396.831$329.534
Income From Discontinued Operations------
Net Income$238.616$523.367$447.098$487.848$396.831$329.535
EBITDA$712.985$948.926$875.529$724.022$727.567$639.014
EBIT$378.073$532.374$614.838$528.842$591.654$508.22
Basic Shares Outstanding565760606161
Shares Outstanding575861616263
Basic EPS$4.28$9.22$7.45$8.13$6.56$5.38
EPS - Earnings Per Share$4.22$9.09$7.30$7.96$6.41$5.23
# 2020 2019 2018 2017 2016 2015
Current Ratio4.34354.47273.57183.29412.90625.5491
Long-term Debt / Capital0.33560.33590.36180.36220.5150.4186
Debt/Equity Ratio0.57240.51660.5790.58271.08110.7434
Gross Margin93.699594.082193.572293.192892.917592.261
Operating Margin15.995924.626932.515332.670939.762438.3619
EBIT Margin15.995924.626932.515332.670939.762438.3619
EBITDA Margin30.165643.89646.301744.728848.896548.2346
Pre-Tax Profit Margin11.63921.015428.000327.251435.783332.9055
Net Profit Margin10.095624.210223.644430.138426.669224.8743
Asset Turnover0.36160.39030.36340.31590.310.3975
Inventory Turnover Ratio1.5611.62742.29522.5483.09495.271
Receiveable Turnover5.96126.07267.1677.22216.35226.3181
Days Sales In Receivables61.22960.106250.92850.53957.460157.7709
ROE - Return On Equity6.5216.823216.214417.981221.13820.6133
Return On Tangible Equity47.1209-209.3349-49.5926-40.1995-19.5631-135.0003
ROA - Return On Assets3.65099.44898.59239.52158.26699.8882
ROI - Return On Investment4.33211.171510.348411.469310.251711.9852
Book Value Per Share65.153655.414747.951845.295331.383126.0769
Operating Cash Flow Per Share2.42730.44141.74621.72851.13611.9289
Free Cash Flow Per Share2.8646-0.45882.6681.4131.54991.939